Have the biosimilar floodgates been opened in the United States?

被引:0
|
作者
Courtenay C. Brinckerhoff
Kristel Schorr
机构
[1] Chemical,
[2] Biotechnology and Pharmaceutical Practice at Foley & Lardner LLP,undefined
[3] 3000 K Street N.W.,undefined
[4] Suite 600,undefined
[5] Washington,undefined
[6] DC 20007-5109,undefined
[7] USA,undefined
[8] and the Editor of Foley & Lardner LLP's PharmaPatentsBlog.com.,undefined
[9] Chemical,undefined
[10] Biotechnology and Pharmaceutical Practice at Foley & Lardner LLP,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:303 / 304
页数:1
相关论文
共 50 条